IBRX stock pre market: trading at $9.55 ahead of Mar 2 earnings, guidance is key

We see ImmunityBio, Inc. (IBRX) trading pre market at $9.55 USD on the NASDAQ as investors position before the company reports quarterly results on 2026-03-02. IBRX stock has posted a dramatic YTD move of +372.77% and average volume has risen to 37,880,583.00 shares. Key facts to watch in the IBRX earnings release include revenue trends, late-stage trial updates, and management guidance that could explain the gap between clinical progress and the current $9.41B market cap.